annual cash & cash equivalents:
$383.33M+$15.11M(+4.10%)Summary
- As of today (September 9, 2025), CORT annual cash & cash equivalents is $383.33 million, with the most recent change of +$15.11 million (+4.10%) on December 31, 2024.
- During the last 3 years, CORT annual cash & cash equivalents has risen by +$159.80 million (+71.49%).
- CORT annual cash & cash equivalents is now -13.02% below its all-time high of $440.70 million, reached on December 31, 2020.
Performance
CORT Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$342.23M+$19.46M(+6.03%)Summary
- As of today (September 9, 2025), CORT quarterly cash & cash equivalents is $342.23 million, with the most recent change of +$19.46 million (+6.03%) on June 30, 2025.
- Over the past year, CORT quarterly cash & cash equivalents has dropped by -$130.93 million (-27.67%).
- CORT quarterly cash & cash equivalents is now -27.67% below its all-time high of $473.16 million, reached on June 30, 2024.
Performance
CORT quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CORT Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.1% | -27.7% |
| 3 y3 years | +71.5% | -7.5% |
| 5 y5 years | +38.9% | -15.6% |
CORT Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.2% | +71.5% | -27.7% | +6.0% |
| 5 y | 5-year | -13.0% | +71.5% | -27.7% | +53.1% |
| alltime | all time | -13.0% | +3953.9% | -27.7% | +3705.3% |
CORT Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $342.23M(+6.0%) |
| Mar 2025 | - | $322.76M(-15.8%) |
| Dec 2024 | $383.33M(+4.1%) | $383.33M(+0.8%) |
| Sep 2024 | - | $380.34M(-19.6%) |
| Jun 2024 | - | $473.16M(+15.2%) |
| Mar 2024 | - | $410.76M(+11.6%) |
| Dec 2023 | $368.22M(-14.7%) | $368.22M(+3.7%) |
| Sep 2023 | - | $355.23M(-2.2%) |
| Jun 2023 | - | $363.26M(-21.9%) |
| Mar 2023 | - | $465.06M(+7.7%) |
| Dec 2022 | $431.67M(+93.1%) | $431.67M(+8.9%) |
| Sep 2022 | - | $396.26M(+7.1%) |
| Jun 2022 | - | $370.09M(+7.1%) |
| Mar 2022 | - | $345.53M(+54.6%) |
| Dec 2021 | $223.53M(-49.3%) | $223.53M(-38.1%) |
| Sep 2021 | - | $361.33M(-2.3%) |
| Jun 2021 | - | $369.98M(-0.8%) |
| Mar 2021 | - | $372.96M(-15.4%) |
| Dec 2020 | $440.70M(+59.7%) | $440.70M(+2.8%) |
| Sep 2020 | - | $428.79M(+5.8%) |
| Jun 2020 | - | $405.36M(+31.9%) |
| Mar 2020 | - | $307.31M(+11.4%) |
| Dec 2019 | $275.96M(+33.5%) | $275.96M(+19.1%) |
| Sep 2019 | - | $231.65M(+14.9%) |
| Jun 2019 | - | $201.54M(+7.8%) |
| Mar 2019 | - | $186.91M(-9.6%) |
| Dec 2018 | $206.76M(+133.0%) | $206.76M(+5.9%) |
| Sep 2018 | - | $195.19M(+22.0%) |
| Jun 2018 | - | $159.94M(+27.6%) |
| Mar 2018 | - | $125.36M(+41.3%) |
| Dec 2017 | $88.74M(+72.2%) | $88.74M(+18.1%) |
| Sep 2017 | - | $75.16M(+13.6%) |
| Jun 2017 | - | $66.17M(+25.4%) |
| Mar 2017 | - | $52.77M(+2.4%) |
| Dec 2016 | $51.54M(+27.5%) | $51.54M(+7.7%) |
| Sep 2016 | - | $47.87M(+14.5%) |
| Jun 2016 | - | $41.79M(+2.6%) |
| Mar 2016 | - | $40.74M(+0.8%) |
| Dec 2015 | $40.44M(+66.8%) | $40.44M(+10.9%) |
| Sep 2015 | - | $36.45M(-1.6%) |
| Jun 2015 | - | $37.05M(-2.4%) |
| Mar 2015 | - | $37.95M(+56.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | $24.25M(-55.8%) | $24.25M(-9.5%) |
| Sep 2014 | - | $26.78M(-21.2%) |
| Jun 2014 | - | $33.97M(-22.1%) |
| Mar 2014 | - | $43.62M(-20.5%) |
| Dec 2013 | $54.88M(-41.0%) | $54.88M(-13.1%) |
| Sep 2013 | - | $63.17M(-12.5%) |
| Jun 2013 | - | $72.22M(-11.3%) |
| Mar 2013 | - | $81.46M(-12.4%) |
| Dec 2012 | $93.03M(+134.7%) | $93.03M(-8.5%) |
| Sep 2012 | - | $101.63M(+191.2%) |
| Jun 2012 | - | $34.90M(-18.1%) |
| Mar 2012 | - | $42.63M(+7.5%) |
| Dec 2011 | $39.63M(+66.1%) | $39.63M(-13.7%) |
| Sep 2011 | - | $45.91M(-12.1%) |
| Jun 2011 | - | $52.23M(-11.8%) |
| Mar 2011 | - | $59.20M(+104.3%) |
| Sep 2010 | - | $28.98M(-18.1%) |
| Jun 2010 | - | $35.38M(+90.8%) |
| Mar 2010 | - | $18.55M(-22.3%) |
| Dec 2009 | $23.87M(+30.4%) | $23.87M(+122.7%) |
| Sep 2009 | - | $10.72M(-25.8%) |
| Jun 2009 | - | $14.45M(-30.0%) |
| Mar 2009 | - | $20.64M(+12.8%) |
| Dec 2008 | $18.31M(+5.4%) | $18.31M(-19.8%) |
| Sep 2008 | - | $22.82M(-12.6%) |
| Jun 2008 | - | $26.12M(-17.8%) |
| Mar 2008 | - | $31.79M(+83.1%) |
| Dec 2007 | $17.37M(+83.7%) | $17.37M(-15.6%) |
| Sep 2007 | - | $20.58M(+72.2%) |
| Jun 2007 | - | $11.95M(-19.0%) |
| Mar 2007 | - | $14.74M(+55.9%) |
| Dec 2006 | $9.46M(-67.5%) | $9.46M(-21.4%) |
| Sep 2006 | - | $12.03M(-31.1%) |
| Jun 2006 | - | $17.46M(-27.1%) |
| Mar 2006 | - | $23.94M(-17.7%) |
| Dec 2005 | $29.08M(-22.2%) | $29.08M(-2.5%) |
| Sep 2005 | - | $29.81M(-7.8%) |
| Jun 2005 | - | $32.34M(-13.5%) |
| Dec 2004 | $37.40M(+73.6%) | $37.40M(-23.5%) |
| Sep 2004 | - | $48.91M(-6.0%) |
| Jun 2004 | - | $52.03M(+478.6%) |
| Mar 2004 | - | $8.99M |
| Dec 2002 | $21.54M | - |
FAQ
- What is Corcept Therapeutics Incorporated annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual cash & cash equivalents year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly cash & cash equivalents year-on-year change?
What is Corcept Therapeutics Incorporated annual cash & cash equivalents?
The current annual cash & cash equivalents of CORT is $383.33M
What is the all time high annual cash & cash equivalents for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual cash & cash equivalents is $440.70M
What is Corcept Therapeutics Incorporated annual cash & cash equivalents year-on-year change?
Over the past year, CORT annual cash & cash equivalents has changed by +$15.11M (+4.10%)
What is Corcept Therapeutics Incorporated quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of CORT is $342.23M
What is the all time high quarterly cash & cash equivalents for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly cash & cash equivalents is $473.16M
What is Corcept Therapeutics Incorporated quarterly cash & cash equivalents year-on-year change?
Over the past year, CORT quarterly cash & cash equivalents has changed by -$130.93M (-27.67%)